Chengdu Kanghong Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 8.8% in First Three Quarters of 2023

Chengdu Kanghong Pharmaceutical Group Co.,Ltd. (成都康弘药业集团股份有限公司) (002773.SZ) reported a net profit of 816.2 million yuan in the first three quarters of 2023, up 8.8% year-on-year.

Meanwhile, the company posted 3 billion yuan in revenue, up 14% year-on-year.

At the end of the reporting period, it had 8.4 billion yuan in total assets and 796.8 million yuan in total liabilities, with a liability-to-asset ratio of 9.5%.